Predica is proud to announce its first product, the “HPV profiler”.

This RUO assay is based on Predica’s targeted RNA sequencing platform and allows unique insights in HPV biology and HPV related diseases.

 

Completion of this product is a great milestone, and will set the stage for our future development of diagnostic tools for Women's Health (Cervical Cancer, Vaginal Health and Endometriosis).

 

Please contact us if you are interested to learn more about our developments

Previous
Previous

Predica’s CSO attends the IPVC2024 in Edinburgh, 12 - 15 Nov.

Next
Next

MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology